Clinical Study on the Metastasis to the Eyes from Breast Cancer

スポンサーリンク

概要

論文の詳細を見る
2004-01-10

著者

Kasumi Fujio
Department of Surgery and Pathology, Cancer Institute Hospital
三木義男
癌研ゲノムセンター
Tsuruo T
Division Of Experimental Chemotherapy Cancer Chemotherapy Center Japanese Foundation For Cancer Rese
Yoshimoto M
The Cancer Institute Of Japanese Foundation For Cancer Research (jfcr)
Tamura Miki
Department Of Breast Surgery Cancer Institute Hospital
Matsumoto-mishima Yuko
癌研究会癌化学療法センター臨床研究部
Yoshimoto Masataka
Department of Surgery and Pathology, Cancer Institute
Kobayashi Takayuki
Cancer Inst. Hospital Tokyo Jpn
TAKAHASHI Kaoru
Department of Applied Physics, Tokyo University of Agriculture and Technology
Fukino K
Department Of Breast Surgery The Cancer Institute Hospital Of Jfcr
Kasumi Fujio
Department Of Breast Surgery Cancer Institute Hospital
Tada Takashi
Department of Surgery and Pathology, Cancer Institute
Tajiri T
Department Of Surgery I Nippon Medical School
TADA Keiichiro
Department of Medical Oncology Cancer Institute Hospital
Kutomi Goro
Department Of Breast Surgery Cancer Institute Hospital
TSUJI Hideki
Department of Ophthalmology, Cancer Institute Hospital
TAMURA Megumi
Department of Ophthalmology, Cancer Institute Hospital
TANABE Masahiko
Department of Breast Surgery, Cancer Institute Hospital
SEKINE Yasuko
Department of Breast Surgery, Cancer Institute Hospital
Kasumi Fujio
Department Of Breast Surgery The Cancer Institute Hospital Of Jfcr
Fukino Koichi
Department Of Neurosurgery Nippon Medical School
Tamura Megumi
Department Of Ophthalmology Cancer Institute Hospital
Sekine Yasuko
Department Of Breast Surgery Cancer Institute Hospital
Tada Keiichiro
Department Of Breast Oncology Cancer Institute Hospital Japanese Foundation For Cancer Research
Tada Keiichiro
Department Of Breast Surgery Cancer Institute Hospital
Kasahara T
Department Of Biochemistry Kyoritsu University Of Pharmacy
Kinoshita Takayuki
Division Of Surgery National Cancer Center Hospital
Tada Takashi
Department Of Nuclear Medicine Cancer Institute Hospital
Tanabe Masahiko
Department Of Breast Surgery Cancer Institute Hospital
Kitahara Takashi
Department Of Breast Surgery Cancer Institute Hospital
Tsuji Hideki
Department Of Ophthalmology Cancer Institute Hospital
Tada Keiichiro
Division Of Clinical Chemotherapy Cancer Chemotherapy Center Japanese Foundation For Cancer Research
Takahashi Kaoru
Department Of Breast Oncology Cancer Institute Hospital Of Japanese Foundation For Cancer Research
Takahashi Kaoru
Department Of Applied Physics Tokyo University Of Agriculture And Technology
Tada Takashi
Department Of Development And Differentiation Institute For Frontier Medical Sciences Kyoto Universi
Yoshimoto Masataka
Department Of Molecular Diagnosis Cancer Institute Japanese Foundation For Cancer Research
Takagi Koichi
Department Of Medical Oncology Cancer Institute Hospital Of Japanese Foundation For Cancer Research
Sekine Yasuko
Deparrment of Public Health, Kyorin University School of Medicine
Tamura Miki
Department of Applied Chemistry, Graduate School of Engineering, Kyushu University

関連論文

ゲノム情報を生かした個別化医療 (特集固形癌の最新治療--癌治療への新たな取り組み) -- (治療の新たな取り組み個別化治療)
Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
Overrepresentation of the EBAG9 Gene at 8q23 Associated with Early-Stage Breast Cancers
P-674 大腸癌肝転移切除例のSurgical Marginについての遺伝子学的および組織学的検討
PP-1137 大腸癌肝転移に対する外科的治療戦略 : Surgical Marginについての遺伝子学的および臨床病理学的検討
SF-107-4 大腸sm癌のリンパ節転移と遺伝子群のマイクロアレイによる解析(第107回日本外科学会定期学術集会)
大腸の増殖形式(PG・NPG)と遺伝子群のマイクロアレイによる解析,悪性度についての検討
マイクロアレイによる大腸癌の異時性肝転移の高リスク群の抽出
SY-1-2-5 肝細胞癌の進展機構解析による新規分子標的の同定(シンポジウム1-2 消化器癌の発生機序から見た治療戦略-肝胆膵癌,第62回日本消化器外科学会定期学術総会)
PS-095-1 n0乳癌における再発予後予測システムの検討
SY-6-6 癌遺伝子発現パターンを用いたPaclitaxelの治療効果予知 : 局所進行乳癌に対する術前化療による解析
早期大腸癌の発育形態と Ras-signaling Pathway 異常(第105回日本外科学会定期学術集会)
PS-117-2 散発性大腸癌発癌におけるhMLH1発現低下の意義
Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy
Diffuse large B-cell lymphoma after transformation from low-grade follicular lymphoma : morphological, immunohistochemical, and FISH analyses
Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
A-3 インベーダ法によるSNP遺伝子型データの2変量正規混合分布に基づく分類(企画セッション:SNPデータの解析における統計的諸問題)(2003年度統計関連学会連合大会記録(日本統計学会第71回大会))
Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients
発がん・増殖 BRCA遺伝子機能とその機能欠損による乳癌発生機序 (乳癌--基礎と臨床の架け橋)
図説最新のゲノムワイド解析技術 (特集ゲノム研究最前線--疾患ゲノム研究の現状と展望)
癌と骨転移のゲノム学 (特集骨・破壊と再生のゲノム医学)
遺伝性乳癌の分子遺伝学--BRCA1を中心に (癌抑制遺伝子--最新トピックス)
SNPsと有害事象情報 (特集分子・細胞標的治療--基礎と臨床) -- (基礎)
がんの遺伝解析 (特集ポストゲノム時代の医療) -- (ゲノム解析からの病態解明)
大腸癌表層部と先進部の発現プロファイル解析
IS-3-4 乳がん術前化学療法の効果予測システム開発の試み(第108回日本外科会定期学術集会)
A Japanese patient with Li-Fraumeni syndrome who had nine primary malignancies associated with a germline mutation of the p53 tumor-suppressor gene
SF-108-2 大腸癌先進部脱分化に関与する遺伝子群の同定と機能ネットワークの構築(第107回日本外科学会定期学術集会)
O-109 原発性肺癌切除時の開胸時胸腔内洗浄液における微量肺癌細胞の検出と細胞診の比較(肺癌と分子生物学2, 第47回日本肺癌学会総会)
DP-009-4 包括的遺伝子発現解析による膵癌リンパ節転移予測マーカーの同定(第108回日本外科学会定期学術集会)
Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission
Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma
Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer
Management of infection in patients with acute leukemia during chemotherapy in Japan : questionnaire analysis by the Japan Adult Leukemia Study Group
A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL
P-7 原発性肺癌切除時の開胸時胸腔内洗浄液におけるCEA-mRNAの検出の意義(一般演題(ポスター) トランスレーショナルリサーチ,第48回日本肺癌学会総会)
Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
乳がんのLarge-scale genomic study
Monosomies 7p and 12p and FLT3 internal tandem duplication : possible markers for diagnosis of T/myeloid biphenotypic acute leukemia and its clonal evolution
Allelic Losses of Loci at 3p25.1,8p22,13q12,17p13.3,and 22q13 Correlate with Postoperative Recurrence in Breast Cancer
Successful cord blood transplantation for mycosis fungoides.
Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma
Primary Hepatic Follicular Lymphoma : A Case Report and Discussion of Chemotherapy and Favorable Outcomes
HNPCC患者の放射線治療の安全性に関する検討(第105回日本外科学会定期学術集会)
Histological Features of Breast Cancer, Highly Sensitive to Chemotherapy
Identifying haplotype block structure using an ancestor-derived model
Increased incidence of interstitial pneumonia by CHOP combined with rituximab
Impaired TCR signaling through dysfunction of lipid rafts in sphingomyelin synthase 1 (SMS1)-knockdown T cells
Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study
Allelic Loss at 1p34,13q12,17p13.3,and 17q21.1 Correlates With Poor Postoperative Prognosis in Breast Cancer
Correlation of Allelic Loss with Poor Postoperative Survival in Breast Cancer
Frequent Allelic Loss at 6q26-27 in Breast Carcinomas of the Solid-tubular Histologic Type
Detailed Deletion Mapping of Chromosome Arm 3p in Breast Cancers : A 2-cM Region on 3p 14.3-21.1 and a 5-cM Region on 3p 24.3-25.1 Commonly Deleted in Tumors
Correlation of Allelic Losses and Clinicopathological Factors in Primary Breast Cancers
Mapping of a Breast Cancer Tumor Suppressor Gene Locus to a 4-cM Interval on Chromosome 18q21
Efficacy and Safety of Combined Trastuzumab and Paclitaxel Therapy as a Second-Line Treatment in Women with Metastatic Breast Cancer : A Single Institutional Experience
High Prevalence of HER-2/neu and p53 Overexpression in Inflammatory Breast Cancer
Severe Infusion Reaction Induced by Trastuzumab : A Case Report
Clinicopathological Features of Hereditary Breast Cancer
Expression profiling to predict postoperative prognosis for estrogen receptor-negative breast cancers by analysis of 25,344 genes on a cDNA microarray
Allelic Loss on Chromosome 9q Is Associated with Lymph Node Metastasis of Primary Breast Cancer
Tocilizumab is effective for pulmonary hypertension associated with multicentric Castleman's disease
Identification of Rad51 alteration in patients with bilateral breast cancer
High proportion of missense mutations of the BRCA1 and BRCA2 genes in Japanese breast cancer families
Multiplex Mutation Screening of the BRCA1 Gene in 1000 Japanese Breast Cancers
Infrequent Mutation of the H-Cadherin Gene on Chromosome 16q24 in Human Breast Cancers
Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer
Bilateral Nonpalpable Breast Carcinomas in a Patient with BRCA2 Germ Line Mutation and Past History of Osteosarcoma
Clinical features of adult acute leukemia with 11q23 abnormalities in Japan : a co-operative multicenter study
癌抑制遺伝子BRCA1/2の機能およびPARP阻害剤によるBRCA変異陽性乳癌の治療 (特集癌治療・発癌・老化の鍵を握るDNA修復経路)
Allelic Loss at 1p34-36 Predicts Poor Prognosis in Node-negative Breast Cancer
Surgery for Ductal Carcinoma in situ
Mapping of a New Target Region of Allelic Loss to a 6-cM Interval at 21q21 in Primary Breast Cancers
Tolerability and Safety of Classic Cyclophosphamide, Methotrexate, and Fluorouracil Treatment in Japanese Patients with Early Breast Cancer
Clinical Study on the Metastasis to the Eyes from Breast Cancer
Intraductal Papilloma with Bloody Discharge from Montgomery's Areolar Tubercle Examined by Ductoscopy from the Areola
Diagnostic Mammography and Ultrasonography for Palpable and Nonpalpable Breast Cancer in Women Aged 30 to 39 Years
Diagnostic Ultrasonography and Mammography for Invasive and Noninvasive Breast Cancer in Women Aged 30 to 39 Years
Improved detection of axillary hot nodes in lymphoscintigraphy in breast cancer located in the upper lateral quadrant with additional projection imaging
What is the Predictor for Invasion in Non-palpable Breast Cancer with Microcalcifications?
Mammographic and Clinicopathological Features of Mucinous Carcinoma of the Breast
Two Distinct Commonly Deleted Regions on Chromosome 13q Suggest Involvement of BRCA2 and Retinoblastoma Genes in Sporadic Breast Carcinomas
Frequent Allelic Loss at 7p14-15 Associated with Aggressive Histologic Types of Breast Cancer
Mapping of a New Target Region of Allelic Loss to a 2-cM Interval at 22q 13.1 in Primary Breast Cancer
A Clinicopathologic Study of Breast Cancer Patients during Pregnancy
Endoscopic Classification of Intraductal Lesions and Histological Diagnosis
Mutation Analysis of the mel-18 Gene that Shows Decreased Expression in Human Breast Cancer Cell Lines
Evaluation of HER-2 Status in Breast Carcinoma by Fluorescence in situ Hybridization and Immunohistochemistry
Allelic Loss on Chromosome 1p Is Associated with Progression and Lymph Node Metastasis of Primary Breast Carcinoma
Allelic losses as prognostic markers for breast cancers
Mapping of Target Regions of Allelic Loss in Primary Breast Cancers to 1-cM Intervals on Genomic Contigs at 6q21 and 6q25.3

もっと見る閉じる

スポンサーリンク

論文relation | CiNii API
論文
論文著者
博士論文
研究課題
研究者
図書
論文
著者
お問い合わせ
プライバシー